resveratrol has been researched along with Colitis Gravis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (66.67) | 24.3611 |
2020's | 5 (33.33) | 2.80 |
Authors | Studies |
---|---|
Duan, L; Xiao, B; Xie, D; Zhou, X; Zhu, Z | 1 |
Chen, L; Chen, T; Hu, J; Hua, Z; Li, Y; Luo, F; Wu, D; Xu, Y; Zhao, R | 1 |
Chen, YH; Xiang, Y | 1 |
Alrafas, HR; Busbee, PB; Nagarkatti, M; Nagarkatti, PS | 1 |
Cui, XL; DU, XX; Liu, KL; Liu, X; Wu, YL; Zhang, WQ | 1 |
Dua, K; Gandhi, H; Negi, P; Rathore, C; Tambuwala, MM; Vihal, S | 1 |
Bagheri, N; Larussa, T; Luzza, F; Rahimian, G; Sabzevary-Ghahfarokhi, M; Shirzad, H; Soltani, A | 1 |
Byun, EB; Byun, EH; Kim, JM; Kim, WS; Mushtaq, S; Song, HY; Yuk, JM | 1 |
Abdin, AA | 1 |
Asl, PR; Daryani, NE; Hekmatdoost, A; Samsami-Kor, M | 1 |
Asl, PR; Daryani, NE; Hekmatdoost, A; Samsamikor, M | 1 |
Cárdeno, A; de la Lastra, CA; Sánchez-Fidalgo, S; Talero, E; Villegas, I | 1 |
Feng, JL; Jia, CH; Li, YX; Liu, L; Wang, JY; Wang, LS; Wei, XX; Xun, AY; Yao, J; Zeng, WS; Zhao, L | 2 |
Abdallah, DM; Ismael, NR | 1 |
1 review(s) available for resveratrol and Colitis Gravis
Article | Year |
---|---|
Efficacy of resveratrol for the treatment in patients with ulcerative colitis: Study Protocol.
Topics: Colitis, Ulcerative; Humans; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Research Design; Resveratrol | 2019 |
2 trial(s) available for resveratrol and Colitis Gravis
Article | Year |
---|---|
Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Quality of Life; Resveratrol; Stilbenes; Surveys and Questionnaires; Young Adult | 2015 |
Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
Topics: Adult; Antioxidants; Colitis, Ulcerative; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Prospective Studies; Quality of Life; Resveratrol; Stilbenes; Superoxide Dismutase; Surveys and Questionnaires | 2016 |
12 other study(ies) available for resveratrol and Colitis Gravis
Article | Year |
---|---|
Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Drug Carriers; Fibroins; Humans; Lipopolysaccharides; Mucus; Nanoparticles; Poloxamer; Reactive Oxygen Species; Resveratrol; Tumor Necrosis Factor-alpha | 2022 |
Efficient oral delivery of resveratrol-loaded cyclodextrin-metal organic framework for alleviation of ulcerative colitis.
Topics: Animals; Colitis, Ulcerative; Cyclodextrins; Hydrogels; Metal-Organic Frameworks; Mice; Resveratrol | 2023 |
Resveratrol Downregulates miR-31 to Promote T Regulatory Cells during Prevention of TNBS-Induced Colitis.
Topics: Animals; Case-Control Studies; Colitis; Colitis, Ulcerative; Down-Regulation; Female; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Mice, Inbred C57BL; MicroRNAs; Resveratrol; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid | 2020 |
[Effects of resveratrol on ulcerative colitis in mice and its mechanism].
Topics: Animals; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Resveratrol | 2019 |
Efficacy of resveratrol encapsulated microsponges delivered by pectin based matrix tablets in rats with acetic acid-induced ulcerative colitis.
Topics: Acetic Acid; Animals; Antioxidants; Chemistry, Pharmaceutical; Chitosan; Colitis, Ulcerative; Colon; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Particle Size; Pectins; Rats; Rats, Wistar; Resveratrol; Tablets | 2020 |
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein.
Topics: Adult; Caco-2 Cells; Colitis, Ulcerative; Down-Regulation; Female; Gene Expression Regulation; Humans; Interleukin-11; Interleukin-1beta; Male; NF-E2-Related Factor 2; Resveratrol; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |
Therapeutic Potential of Gamma-Irradiated Resveratrol in Ulcerative Colitis via the Anti-Inflammatory Activity and Differentiation of Tolerogenic Dendritic Cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Colitis, Ulcerative; Dendritic Cells; Gamma Rays; Immune Tolerance; Mice; Mice, Inbred BALB C; Resveratrol | 2019 |
Targeting sphingosine kinase 1 (SphK1) and apoptosis by colon-specific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats.
Topics: Animals; Apoptosis; Caspase 3; Chemistry, Pharmaceutical; Colitis, Ulcerative; Colon; DNA Fragmentation; Drug Delivery Systems; Humans; Molecular Targeted Therapy; Organ Specificity; Oxazolone; Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Wistar; Resveratrol; Stilbenes | 2013 |
Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colitis, Ulcerative; Colon; Cyclooxygenase 2; Cytokines; Dextran Sulfate; Dietary Supplements; Disease Models, Animal; Female; Intramolecular Oxidoreductases; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Organ Size; p38 Mitogen-Activated Protein Kinases; Prostaglandin-E Synthases; Random Allocation; Resveratrol; Signal Transduction; Stilbenes | 2010 |
Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis.
Topics: Animals; Antioxidants; Base Sequence; Blotting, Western; Colitis, Ulcerative; Colon; Dextran Sulfate; DNA Primers; Enzyme-Linked Immunosorbent Assay; Glutathione Peroxidase; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Peroxidase; Reactive Oxygen Species; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2010 |
Polydatin ameliorates DSS-induced colitis in mice through inhibition of nuclear factor-kappaB activation.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Glucosides; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Peroxidase; Pilot Projects; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Tumor Necrosis Factor-alpha | 2011 |
Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cell Adhesion Molecules; Colitis, Ulcerative; Colon; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glutathione; Inflammation; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Peroxidase; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfasalazine; Trinitrobenzenesulfonic Acid; Vascular Cell Adhesion Molecule-1 | 2011 |